Article Per Year (5 Year)
p-Index From 2020 - 2025
0.23
P-Index
This Author published in this journals
All Journal Medical Sains : Jurnal Ilmiah Kefarmasian
Eka Gumilang, Nurani
Unknown Affiliation
Medicine & Pharmacology

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
RATIONALITY AND COST COMPARISON OF OUTPATIENT TYPE 2 DM THERAPY UNDER INA-CBGS: A LITERATURE REVIEW Eka Gumilang, Nurani; Sulaeman, Agus
Medical Sains : Jurnal Ilmiah Kefarmasian Vol 10 No 2 (2025)
Publisher : Universitas Muhammadiyah Ahmad Dahlan Cirebon

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37874/ms.v10i2.1720

Abstract

This literature review evaluates the rationality of Type 2 Diabetes Mellitus (T2DM) therapy and analyzes the cost comparison between treatment expenses and Indonesian Case-Based Groups (INA-CBGs) tariffs for outpatient hospital care. The findings indicate that evidence-based therapy is essential for improving clinical effectiveness and cost efficiency. Several studies have highlighted significant discrepancies between actual outpatient treatment costs and INA-CBGs tariffs, with pharmaceutical expenses being the primary factor contributing to hospital cost deficits. A review was conducted using 11 peer-reviewed studies from 2019 to 2024, selected based on inclusion criteria such as relevance to outpatient T2DM therapy under INA-CBGs, full-text availability, and publication in Indonesian or English language. This review recommends policy adjustments to strengthen a transparent claims system, optimize an evidence-based national formulary, and enhance complication prevention strategies to improve the efficiency of DM management in Indonesia. Keywords: rationality of therapy, Type 2 Diabetes Mellitus, treatment cost, INA-CBGs, hospital, outpatient
Co-Authors Agus Sulaeman